Back to Search Start Over

Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19

Authors :
Hiroyuki Futatsugi
Masato Iwabu
Miki Okada-Iwabu
Koh Okamoto
Yosuke Amano
Yutaka Morizaki
Takashi Kadowaki
Toshimasa Yamauchi
Source :
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Publication Year :
2020
Publisher :
Frontiers Media S.A., 2020.

Abstract

Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19.

Details

Language :
English
ISSN :
2297055X
Volume :
7
Database :
Directory of Open Access Journals
Journal :
Frontiers in Cardiovascular Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.f0aa54921026453193573d7c060a9738
Document Type :
article
Full Text :
https://doi.org/10.3389/fcvm.2020.593061